1. Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX. (September 2017) Authors: Thaler, Josef; Greil, Richard; Gaenzer, Johannes; Eisterer, Wolfgang; Tschmelitsch, Joerg; Keil, Felix; Samonigg, Hellmut; Zabernigg, August; Schmid, Franz; Steger, Günther; Steinacher, Robert; Andel, Johannes; Jagdt, Björn; Lang, Alois; Fridrik, Michael; Függer, Reinhold; Hofbauer, Friedrich; Wo... Journal: European journal of cancer Issue: Volume 82(2017) Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Single‐Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial). (17th August 2018) Authors: García‐Alfonso, Pilar; Benavides, Manuel; Falcó, Esther; Muñoz, Andrés; Gómez, Auxiliadora; Sastre, Javier; Rivera, Fernando; Montagut, Clara; Salgado, Mercedes; López‐Ladrón, Amelia; López, Rafael; Ruiz de Mena, Inmaculada; Durán, Gema; Aranda, Enrique Journal: Oncologist Issue: Volume 23:Number 11(2018) Page Start: 1271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Venous Thromboembolism In Cancer Patients: "From Evidence to Care". (May 2022) Authors: Salgado, Mercedes; Brozos-Vázquez, Elena; Campos, Begoña; González-Villarroel, Paula; Pérez, María Eva; Vázquez-Tuñas, María Lidia; Arias, David Journal: Clinical and applied thrombosis/hemostasis Issue: Volume 28(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗